BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 24119645)

  • 1. A xeno-free culture method that enhances Wharton's jelly mesenchymal stromal cell culture efficiency over traditional animal serum-supplemented cultures.
    Julavijitphong S; Wichitwiengrat S; Tirawanchai N; Ruangvutilert P; Vantanasiri C; Phermthai T
    Cytotherapy; 2014 May; 16(5):683-91. PubMed ID: 24119645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.
    He H; Nagamura-Inoue T; Tsunoda H; Yuzawa M; Yamamoto Y; Yorozu P; Agata H; Tojo A
    Tissue Eng Part A; 2014 Apr; 20(7-8):1314-24. PubMed ID: 24279891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
    Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
    Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton's jelly matrix.
    Hendijani F; Sadeghi-Aliabadi H; Haghjooy Javanmard S
    Cell Tissue Bank; 2014 Dec; 15(4):555-65. PubMed ID: 24532125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice.
    Milazzo L; Vulcano F; Barca A; Macioce G; Paldino E; Rossi S; Ciccarelli C; Hassan HJ; Giampaolo A
    Eur J Haematol; 2014 Nov; 93(5):384-91. PubMed ID: 24797266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human umbilical cord Wharton's jelly-derived mesenchymal stem cells differentiate into a Schwann-cell phenotype and promote neurite outgrowth in vitro.
    Peng J; Wang Y; Zhang L; Zhao B; Zhao Z; Chen J; Guo Q; Liu S; Sui X; Xu W; Lu S
    Brain Res Bull; 2011 Feb; 84(3):235-43. PubMed ID: 21194558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple and serum-free protocol for cryopreservation of human umbilical cord as source of Wharton's jelly mesenchymal stem cells.
    Roy S; Arora S; Kumari P; Ta M
    Cryobiology; 2014 Jun; 68(3):467-72. PubMed ID: 24704519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton's jelly derived mesenchymal stem cells? A comparative study.
    Swamynathan P; Venugopal P; Kannan S; Thej C; Kolkundar U; Bhagwat S; Ta M; Majumdar AS; Balasubramanian S
    Stem Cell Res Ther; 2014 Jul; 5(4):88. PubMed ID: 25069491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of canine Wharton's jelly-derived mesenchymal stem cells.
    Seo MS; Park SB; Kang KS
    Cell Transplant; 2012; 21(7):1493-502. PubMed ID: 22732242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive selection of Wharton's jelly-derived CD105(+) cells by MACS technique and their subsequent cultivation under suspension culture condition: A simple, versatile culturing method to enhance the multipotentiality of mesenchymal stem cells.
    Amiri F; Halabian R; Dehgan Harati M; Bahadori M; Mehdipour A; Mohammadi Roushandeh A; Habibi Roudkenar M
    Hematology; 2015 May; 20(4):208-16. PubMed ID: 25116042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogenicity, efficiency and biosafety analysis in xeno-free human amniotic stem cells for regenerative medical therapies.
    Phermthai T; Thongbopit S; Pokathikorn P; Wichitwiengrat S; Julavijitphong S; Tirawanchai N
    Cytotherapy; 2017 Aug; 19(8):990-1001. PubMed ID: 28566211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial transfer from Wharton's jelly-derived mesenchymal stem cells to mitochondria-defective cells recaptures impaired mitochondrial function.
    Lin HY; Liou CW; Chen SD; Hsu TY; Chuang JH; Wang PW; Huang ST; Tiao MM; Chen JB; Lin TK; Chuang YC
    Mitochondrion; 2015 May; 22():31-44. PubMed ID: 25746175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of a novel embryonic stem cell cord blood-derived population with in vitro hematopoietic capacity in the presence of Wharton's jelly-derived mesenchymal stromal cells.
    Gounari E; Daniilidis A; Tsagias N; Michopoulou A; Kouzi K; Koliakos G
    Cytotherapy; 2019 Feb; 21(2):246-259. PubMed ID: 30522805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.
    Cardoso TC; Ferrari HF; Garcia AF; Novais JB; Silva-Frade C; Ferrarezi MC; Andrade AL; Gameiro R
    BMC Biotechnol; 2012 May; 12():18. PubMed ID: 22559872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory effects of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocyte-derived dendritic cells.
    Saeidi M; Masoud A; Shakiba Y; Hadjati J; Mohyeddin Bonab M; Nicknam MH; Latifpour M; Nikbin B
    Iran J Allergy Asthma Immunol; 2013 Mar; 12(1):37-49. PubMed ID: 23454777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Wharton's jelly mesenchymal stem cell secretome display antiproliferative effect on leukemia cell line and produce additive cytotoxic effect in combination with doxorubicin.
    Hendijani F; Javanmard SH; Sadeghi-aliabadi H
    Tissue Cell; 2015 Jun; 47(3):229-34. PubMed ID: 25779671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DMSO- and Serum-Free Cryopreservation of Wharton's Jelly Tissue Isolated From Human Umbilical Cord.
    Shivakumar SB; Bharti D; Subbarao RB; Jang SJ; Park JS; Ullah I; Park JK; Byun JH; Park BW; Rho GJ
    J Cell Biochem; 2016 Oct; 117(10):2397-412. PubMed ID: 27038129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of fibroblast growth factor on distinct differentiation potential of cord blood-derived unrestricted somatic stem cells and Wharton's jelly-derived mesenchymal stem/stromal cells.
    Lee S; Park BJ; Kim JY; Jekarl D; Choi HY; Lee SY; Kim M; Kim Y; Park MS
    Cytotherapy; 2015 Dec; 17(12):1723-31. PubMed ID: 26589753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wharton's jelly mesenchymal stromal cells have contrasting effects on proliferation and phenotype of cancer stem cells from different subtypes of lung cancer.
    Vulcano F; Milazzo L; Ciccarelli C; Eramo A; Sette G; Mauro A; Macioce G; Martinelli A; La Torre R; Casalbore P; Hassan HJ; Giampaolo A
    Exp Cell Res; 2016 Jul; 345(2):190-8. PubMed ID: 27343631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.